Targeting of the mouse gene Xpb. (A) Sequence of the last intron-exon border of the human XPB and XP11BE and the corresponding mouse Xpb alleles. C-to-A transversion (bold) creates a new splice acceptor site (CAG; underlined italics), resulting in a frame-shifted transcript and 40 novel amino acids at the C terminus derived from the frameshift (first five frameshifted amino acids are indicated). A mouse 4-bp insertion in mXpb creates a similar frameshift (Xpbfs; bold). Due to differences in the nucleotide sequence between mice and humans, in mice the 4-bp insertion leads to substitution of the last 41 amino acids to 85 frame-shifted amino acids (G). (B) Schematic representation of the genomic structure and partial restriction map of the WT and targeted mouse Xpb loci. Black box, exon 15; p(A), polyadenylation signal; †, Xpbfs 4-bp insertion. Probes A, B, and C are indicated with thick black lines. Restriction sites are abbreviated as follows: Nc, NcoI; Bg, BglII; B, BamHI; X, XbaI; C, ClaI. The diagnostic BglII site (Bg) introduced in the sequence is indicated in bold italics. (C) Southern blot analysis of NcoI- and BglII-digested genomic DNA from WT and Xpbfs recombinant ES clones hybridized with probes A, C, and B as indicated. (D) Sequence of the last intron-exon border of mouse WT and XpbXPCS alleles. The WT splice acceptor site is underlined.Changed nucleotides in the mutated allele (bold) create an additional 5′ splice acceptor site (underlined) and stop codon (TAG; bold) in the altered reading frame only. Amino acids encoded by both WT and XpbXPCS reading frames are indicated. (E) Genomic structure of the Xpb WT and XpbXPCS alleles. The asterisk indicates the introduced 5′ splice acceptor site. (F) Southern blot analysis of NcoI-digested genomic DNA from WT ES cells (+/+), XpbXPCS recombinant ES clones (+/−), and homozygous XpbXPCS/XPCS mutant mice (−/−) hybridized with probes B and C. (G) Schematic representation of human (NP_000113.1) and mouse (NP_598419.1) XPB proteins derived from alleles depicted in panels A and D. NLS, nuclear localization signal; fs. aa, novel amino acids derived from the frameshift; the C-terminal recognition epitope of 2G12 MAb is indicated with a line. (H) Immunoblot analysis of whole-cell extracts from HeLa cells, two independent homozygous mutant XpbXPCS MEF lines (−/−), and WT MEFs (+/+). Note that the αXPB MAbs 1B3 and 2G12 recognize conserved epitopes within the N and C termini, respectively, and that the C-terminal epitope is absent in the truncated protein (G). The p62 subunit of TFIIH (stained with MAb 3C9; lower panel) served as qualitative control for loading. (I) Reduction of TFIIH protein levels in homozygous XpbXPCS primary MEFs visualized by comparative immunofluorescence assay. WT cells were labeled with 0.79-μm latex beads; XpbXPCS cells were unlabeled (asterisk). Left panel, phase contrast image; right panel, corresponding immunofluorescent image of the p62 subunit of TFIIH. Note the reduced signal in the XpbXPCS cells. (J) Quantification of the TFIIH level in XpbXPCS MEFs. The immunofluorescence signal from XpbXPCS cells was determined (at least 50 nuclei per genotype, two separate experiments with two independent XpbXPCS and WT cell lines) and expressed as the average percentage of the level in WT cells analyzed on the same microscopic slide. Error bars indicate the SEM between experiments. H.sp., Homo sapiens; M.m., Mus musculus.